Gastric-Outlet Obstruction Induced by Prostaglandin Therapy in Neonates

Keyphrases

• Neonate 100%
• Prostaglandins 100%
• Gastric Outlet Obstruction 100%
• Prostaglandin E1 (PGE1) 57%
• Hyperplasia 35%
• Gastric Obstruction 35%
• Ductus Arteriosus 14%
• Clinical Signs 14%
• Patency 14%
• Congenital Heart Disease 14%
• Pathological Evidence 14%
• Radiologic 14%
• Healthy Neonates 14%
• Central Nervous System 7%
• Infusion Rate 7%
• High Probability 7%
• Low Risk 7%
• Recommended Dose 7%
• Cumulative Dose 7%
• Pathological Examination 7%
• Success Probability 7%
• Pulmonary Hypertension 7%
• Persistent Fetal Circulation 7%
• Radiological Assessment 7%
• Mucosal Hyperplasia 7%
• Mucosal Thickening 7%

Medicine and Dentistry

• Neonate 100%
• Prostaglandin 100%
• Pylorus Stenosis 100%
• Prostaglandin E1 50%
• Hyperplasia 37%
• Stomach Obstruction 31%
• Ductus Arteriosus 12%
• Infusion 12%
• Body Weight 12%
• Persistent Truncus Arteriosus 12%
• Central Nervous System 6%
• Cardiovascular System 6%
• Infusion Rate 6%
• Recommended Drug Dose 6%
• Persistent Fetal Circulation 6%
• Pulmonary Hypertension 6%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostaglandin E1 100%
• Pylorus Stenosis 100%
• Prostaglandin 100%
• Hyperplasia 75%
• Stomach Obstruction 62%
• Congenital Heart Disease 25%
• Persistent Pulmonary Hypertension 12%
• Pulmonary Hypertension 12%